HH&L Acquisition in an 8-K said it signed a non-redemption agreement with ivestors who’ve agreed to hold 500,000 shares through a proposed extension that would move the SPAC’s deadline from Aug. 9 to Feb. 9, 2024 if shareholders approve.
In return, the investors participating in the NRA would receive 100,000 Class B shares.
The SPAC last month called off a deal with DiaCarta, Ltd. a precision molecular diagnostics company. HH&L alleged wrongdoing by DiaCarta, which the company in a press release said it “vehemently denies.”
HH&L raiused $360 million in a February 2021 IPO. Read more.
